AU2007333737A1 - Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides - Google Patents
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides Download PDFInfo
- Publication number
- AU2007333737A1 AU2007333737A1 AU2007333737A AU2007333737A AU2007333737A1 AU 2007333737 A1 AU2007333737 A1 AU 2007333737A1 AU 2007333737 A AU2007333737 A AU 2007333737A AU 2007333737 A AU2007333737 A AU 2007333737A AU 2007333737 A1 AU2007333737 A1 AU 2007333737A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- alkylene
- alkyl
- group
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87059406P | 2006-12-18 | 2006-12-18 | |
US60/870,594 | 2006-12-18 | ||
PCT/US2007/088011 WO2008077079A1 (en) | 2006-12-18 | 2007-12-18 | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2007333737A1 true AU2007333737A1 (en) | 2008-06-26 |
Family
ID=39536734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2007333737A Abandoned AU2007333737A1 (en) | 2006-12-18 | 2007-12-18 | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2079687A1 (ko) |
JP (1) | JP2010512800A (ko) |
KR (1) | KR20090100407A (ko) |
CN (1) | CN101578264A (ko) |
AU (1) | AU2007333737A1 (ko) |
CA (1) | CA2672205A1 (ko) |
MX (1) | MX2009006617A (ko) |
WO (2) | WO2011028195A2 (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2370473B1 (en) * | 2008-12-10 | 2016-05-11 | The Scripps Research Institute | Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
WO2010096394A2 (en) | 2009-02-17 | 2010-08-26 | Redwood Biosciences, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
US9567386B2 (en) | 2010-08-17 | 2017-02-14 | Ambrx, Inc. | Therapeutic uses of modified relaxin polypeptides |
NZ607069A (en) | 2010-08-17 | 2014-10-31 | Ambrx Inc | Modified relaxin polypeptides and their uses |
WO2012097333A2 (en) | 2011-01-14 | 2012-07-19 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
EP2820030A4 (en) * | 2012-02-29 | 2015-04-15 | Ambrx Inc | INTERLEUKIN-3-POLYPEPTIDE CONJUGATES AND ITS USES |
CN104244989A (zh) * | 2012-02-29 | 2014-12-24 | Ambrx公司 | 含有新颖前药的分子组合物和其用途 |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
SG11201408153YA (en) * | 2012-06-07 | 2015-01-29 | Ambrx Inc | Prostate-specific membrane antigen antibody drug conjugates |
CA2877124A1 (en) * | 2012-06-19 | 2013-12-27 | Ambrx, Inc. | Anti-cd70 antibody drug conjugates |
EP2968552B1 (en) | 2013-03-14 | 2020-03-11 | The Scripps Research Institute | Targeting agent antibody conjugates and uses thereof |
EP2970177A1 (en) | 2013-03-15 | 2016-01-20 | Pfizer Inc. | Indole compounds that activate ampk |
WO2015057834A1 (en) | 2013-10-15 | 2015-04-23 | The California Institute For Biomedical Research | Peptidic chimeric antigen receptor t cell switches and uses thereof |
WO2016154621A1 (en) | 2015-03-26 | 2016-09-29 | The California Institute For Biomedical Research | SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF |
US11091546B2 (en) | 2015-04-15 | 2021-08-17 | The Scripps Research Institute | Optimized PNE-based chimeric receptor T cell switches and uses thereof |
JP2019515677A (ja) | 2016-04-26 | 2019-06-13 | アール.ピー.シェーラー テクノロジーズ エルエルシー | 抗体複合体ならびにそれを作製および使用する方法 |
AU2017345479B2 (en) | 2016-10-19 | 2024-03-21 | The Scripps Research Institute | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
EP3580232B1 (en) | 2017-02-08 | 2023-09-20 | Bristol-Myers Squibb Company | Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof |
KR20210057124A (ko) | 2018-09-11 | 2021-05-20 | 암브룩스, 인코포레이티드 | 인터류킨-2 폴리펩타이드 접합체 및 그의 용도 |
EP3970208A4 (en) * | 2019-05-13 | 2023-07-26 | Shanghai Polaris Biology Co., Ltd. | LABEL FOR MARKING BIOMOLECULES |
CN114524934B (zh) * | 2020-11-23 | 2024-01-30 | 华东理工大学 | 多肽聚合物或多肽模拟物在骨修复中的应用 |
EP4368722A1 (en) * | 2021-07-07 | 2024-05-15 | Ajinomoto Co., Inc. | Method for secretory production of unnatural-amino-acid-containing protein |
WO2024077277A1 (en) | 2022-10-07 | 2024-04-11 | Ambrx, Inc. | Drug linkers and antibody conjugates thereof |
WO2024155627A1 (en) | 2023-01-16 | 2024-07-25 | Ambrx, Inc. | Anti-cd70 antibody-drug conjugates |
WO2024178310A1 (en) | 2023-02-23 | 2024-08-29 | Ambrx, Inc. | Trop2-directed antibody-drug conjugates and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6107329A (en) * | 1995-06-06 | 2000-08-22 | Pfizer, Inc. | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
AU3485999A (en) * | 1998-04-10 | 1999-11-01 | Mayo Foundation For Medical Education And Research | Neo-tryptophan |
US6858577B1 (en) * | 1999-06-29 | 2005-02-22 | Ortho-Mcneil Pharmaceutical, Inc. | Indole peptidomimetics as thrombin receptor antagonists |
EP1291341A4 (en) * | 2000-05-30 | 2005-04-27 | Chugai Pharmaceutical Co Ltd | COMPOUNDS WITH THROMBOPOIETINIC EFFECT |
JP4623962B2 (ja) * | 2001-10-22 | 2011-02-02 | ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク | タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法 |
-
2007
- 2007-12-18 CN CNA2007800469737A patent/CN101578264A/zh active Pending
- 2007-12-18 JP JP2009543156A patent/JP2010512800A/ja active Pending
- 2007-12-18 AU AU2007333737A patent/AU2007333737A1/en not_active Abandoned
- 2007-12-18 MX MX2009006617A patent/MX2009006617A/es not_active Application Discontinuation
- 2007-12-18 EP EP07869463A patent/EP2079687A1/en not_active Withdrawn
- 2007-12-18 KR KR1020097014780A patent/KR20090100407A/ko not_active Application Discontinuation
- 2007-12-18 WO PCT/US2007/088009 patent/WO2011028195A2/en active Application Filing
- 2007-12-18 WO PCT/US2007/088011 patent/WO2008077079A1/en active Application Filing
- 2007-12-18 CA CA002672205A patent/CA2672205A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2010512800A (ja) | 2010-04-30 |
MX2009006617A (es) | 2009-07-24 |
WO2011028195A3 (en) | 2011-06-16 |
CN101578264A (zh) | 2009-11-11 |
CA2672205A1 (en) | 2008-06-26 |
EP2079687A1 (en) | 2009-07-22 |
WO2008077079A1 (en) | 2008-06-26 |
WO2011028195A2 (en) | 2011-03-10 |
KR20090100407A (ko) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1828224B1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2007333737A1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2006332809A1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2013205042B2 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
AU2012202615B2 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |